Surgeons at Virtua Health, a five-hospital system based in Camden, N.J., successfully performed its first left ventricular assist device implantation, the system announced July 1.

The American Heart Association named Stacey Rosen, MD, Northwell Health's senior vice president of women's health and executive director of the Katz Institute for Women's Health, its 2024-25 volunteer president-elect.

Reno, Nev.-based Renown Health is opening the state's first and only comprehensive extracorporeal membrane oxygenation program.

Philadelphia-based Jefferson Health will consolidate all of its cardiac and vascular services under a new institute, established through a "transformational" gift. 

Despite 2019 recommendations from the American College of Cardiology and the American Heart Association warning adults against routinely taking aspirin for heart health, many are still doing so, according to a new study from Cleveland Clinic researchers.

Vutrisiran, a new drug made by Alnylam Pharmaceuticals to treat ATTR amyloidosis with cardiomyopathy, reduced the risk of death by 36% in patients, the drugmaker announced June 24.

The healthcare field is facing a deluge of potential artificial intelligence products, and Durham, N.C.-based Duke Health has opened an AI testing lab to determine which products are the most effective for heart care.

Aurora, Colo.-based Rocky Mountain Regional VA Medical Center paused heart surgeries between 2022 and 2023 due to lack of staff, but did not tell the federal Veterans Health Administration, The Denver Post reported June 24.

Maysville, Ky.-based Meadowview Regional Medical Center has the lowest 30-day readmission rate for heart failure in the country, according to CMS data.

Charlotte, N.C.-based Atrium Health Sanger Heart & Vascular Institute has become the first in the world to implant a new Duo venous stent system.

Stanford (Calif.) University researchers found chronic hypertension in pregnant patients doubled in the last two decades, from 1.8% to 3.7%.

A Seattle-based UW Medicine heart failure program is keeping patients out of the hospital and providing indefinite care for vulnerable heart failure patients.

Patients with heart failure, or suspected of having it, are not being diagnosed quickly enough, according to a study involving 8,000 patients, which was presented June 15 at the Heart Failure Association of the European Society of Cardiology.

With the exception of open heart surgery, Utica, N.Y.-based Wynn Hospital will resume all cardiac procedures June 20. 

Akira Endo, PhD, a Japanese biochemist whose research helped create statins, died June 5 at 90, The New York Times reported June 12.

A new risk assessment for heart disease found that 40% fewer people would meet the criteria for a statin prescription, NBC News reported June 11.

The American Heart Association is celebrating its 100th anniversary.

Charlotte, N.C.-based Atrium Health Sanger Heart & Vascular Institute is among the first institutions in the Carolinas to treat coronary artery disease using a newly FDA-approved device made by Boston Scientific.

Open-heart surgeries at Wynn Hospital in Utica, N.Y., continue to be on hold following an immediate jeopardy citation issued to the facility May 7. The hospital began its 40-day review period this week and surgeries should resume at the end of that time, a spokesperson confirmed to Becker's.

NYC Health + Hospitals has for a third time received an award from HHS for its innovative hypertension care. The New York City public health system is one of 11 organizations in the nation to be recognized, according to a June 5 news release from the system.